Browse

Pulmonary complications after hematopoietic stem cell transplant in children
소아 조혈모세포 이식 후 발생하는 폐 합병증에 대한 연구

DC Field Value Language
dc.contributor.advisor박준동-
dc.contributor.author최유현-
dc.date.accessioned2017-07-19T10:33:17Z-
dc.date.available2017-07-19T10:33:17Z-
dc.date.issued2016-02-
dc.identifier.other000000133625-
dc.identifier.urihttps://hdl.handle.net/10371/132852-
dc.description학위논문 (석사)-- 서울대학교 대학원 : 의학과 소아과학 전공, 2016. 2. 박준동.-
dc.description.abstractBackground: Despite advances in transplantation and supportive care, a considerable number of patients still have poor prognosis with pulmonary complications (PCs) after hematopoietic stem cell transplant (HSCT). This retrospective study evaluated the clinical characteristics, outcomes, and prognostic factors of PCs in HSCT recipients followed-up for 2 years.
Method: We retrospectively analyzed the medical records of 109 recipients of HSCT between 2010 and 2012.
Results: In this study, 55 PC episodes developed in 38 recipients. Non-invasive diagnostic work-ups were preferred, including sputum examination, serology test, and chest computed tomography (85.5%, 72.7%, and 76.4%, respectively). Infection was the most commonly discovered etiology of PCs (61.8%). The incidence of PCs was lower in patients who received autologous transplantation than in those who received other type of transplantation (65.8% vs. 49.3%, p=0.009). Analysis of PCs and morbidities revealed that the mortality rate was 32.7% in 18 episodes that were closely related with multi-organ dysfunction syndrome (MODS) when the PCs were diagnosed (OR, 26.178
-
dc.description.abstractp = 0.001). Hematological dysfunction was the main factor for poor outcome in PCs (OR, 11.6-
dc.description.abstractp = 0.03). Of the HSCT recipients with PCs, 41.8% were transferred to the pediatric intensive care unit (PICU) for respiratory failure, and the associated mortality rate was 73%. After PICU admission, continuous renal replacement therapy was significantly more commonly administered in patients who died than in those who survived (70.6% vs 16.7%, respectively-
dc.description.abstractp = 0.041). Five patients with 16 fatal primary PCs after HSCT who survived showed lesser progress to MODS and received corticosteroid therapy for acute respiratory distress syndrome more frequently than did those who died.
Conclusions: Physicians must closely observe for the existence of any other organ dysfunction in HSCT recipients with PCs, especially hematologic conditions. To manage MODS, early intervention with PICU admission should be considered.
-
dc.description.tableofcontentsIntroduction 1

Materials and Methods 4
Patients 4
Data collection 4
Definition of PCs 7
Statistical analysis 9

Results 11
General patient characteristics 11
Diagnosis of PCs 13
Outcome and prognostic factors of PCs 15
Outcome of fatal primary PCs requiring PICU admission 18

Discussion 21

References 29

국문초록 38
-
dc.formatapplication/pdf-
dc.format.extent496500 bytes-
dc.format.mediumapplication/pdf-
dc.language.isoen-
dc.publisher서울대학교 대학원-
dc.subjecthematopoietic stem cell transplant-
dc.subjectpulmonary complication-
dc.subjectmortality-
dc.subjectpediatric-
dc.subject.ddc610-
dc.titlePulmonary complications after hematopoietic stem cell transplant in children-
dc.title.alternative소아 조혈모세포 이식 후 발생하는 폐 합병증에 대한 연구-
dc.typeThesis-
dc.description.degreeMaster-
dc.citation.pages39-
dc.contributor.affiliation의과대학 의학과-
dc.date.awarded2016-02-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Dept. of Medicine (의학과)Theses (Master's Degree_의학과)
Files in This Item:
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse